BOSTON--(BUSINESS WIRE)--Ikena Oncology, Inc. (Nasdaq: IKNA) (“Ikena”), a targeted oncology company focused on developing cancer therapies targeting key signaling pathways that drive the formation...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--InterVenn Biosciences today announced that Nobel Prize recipient, James P. Allison, has joined the company’s Board of Advisors, effective March...
BROOKLYN, N.Y.--(BUSINESS WIRE)--Brooklyn ImmunoTherapeutics, Inc. (NYSE American: BTX) ("Brooklyn"), a biopharmaceutical company focused on exploring the role that cytokine-based therapy can have in treating...
BURLINGAME, Calif.--(BUSINESS WIRE)--Tallac Therapeutics, Inc. (“Tallac”), a privately held biopharmaceutical company harnessing the power of innate and adaptive immunity to fight cancer, today announced...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--InterVenn Biosciences today announced that Padmanee Sharma, MD, PhD, has joined the Company’s Board of Advisors, effective March 9, 2021....
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--CERo Therapeutics, Inc., a biopharmaceutical company pioneering the development of novel autologous engineered immune cellular therapies, today announced the expansion...
